BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28257169)

  • 1. Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.
    Foster MC; Weiner DE; Bostom AG; Carpenter MA; Inker LA; Jarolim P; Joseph AA; Kusek JW; Pesavento T; Pfeffer MA; Rao M; Solomon SD; Levey AS
    Am J Transplant; 2017 Sep; 17(9):2390-2399. PubMed ID: 28257169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.
    Keddis MT; Howard MR; Galapia L; Barreto EF; Zhang N; Butterfield RJ; Rule AD
    Nephrol Dial Transplant; 2023 Jul; 38(8):1898-1906. PubMed ID: 36646435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
    Inker LA; Coresh J; Sang Y; Hsu CY; Foster MC; Eckfeldt JH; Karger AB; Nelson RG; Liu X; Sarnak M; Appel LJ; Grams M; Xie D; Kimmel PL; Feldman H; Ramachandran V; Levey AS;
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):69-78. PubMed ID: 28062677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
    Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
    Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients.
    Pihlstrøm HK; Mjøen G; Mucha S; Franke A; Jardine A; Fellström B; Dahle DO; Holdaas H; Melum E
    Am J Transplant; 2019 May; 19(5):1444-1451. PubMed ID: 30457209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
    Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients.
    Pihlstrøm H; Mjøen G; März W; Olav Dahle D; Abedini S; Holme I; Fellström B; Jardine A; Pilz S; Holdaaas H
    Clin Transplant; 2014 Jan; 28(1):111-9. PubMed ID: 24372612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.
    Foster MC; Inker LA; Levey AS; Selvin E; Eckfeldt J; Juraschek SP; Coresh J;
    Am J Kidney Dis; 2013 Jul; 62(1):42-51. PubMed ID: 23518194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
    Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients.
    Dahle DO; Åsberg A; Hartmann A; Holdaas H; Bachtler M; Jenssen TG; Dionisi M; Pasch A
    Am J Transplant; 2016 Jan; 16(1):204-12. PubMed ID: 26375609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.